封面
市場調查報告書
商品編碼
1375898

光學基因組圖譜市場規模、佔有率和趨勢分析報告:按產品、按應用、按最終用途、按地區和細分趨勢,2023-2030 年

Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By End-user, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

光學基因組圖譜市場成長與趨勢:

Grand View Research, Inc. 的最新報告顯示,到 2030 年,全球光學基因組圖譜市場規模預計將達到 6.562 億美元。

預計 2023 年至 2030 年該市場將以 29.1% 的年複合成長率成長。這是由於對各種慢性疾病的有效治療方法的研究不斷發展。光學基因組作圖 (OGM) 能夠補充其他基因組定序技術,例如次世代定序(NGS),正在基因組學研究中產生協同效應。

透過將光學圖譜資料與NGS資料整合,研究人員可以獲得更全面的基因組視圖,這在臨床診斷和癌症研究中特別有價值。 2023年8月,Bionano Genomics將參與癌症基因組學聯盟(CGC)2023年年會,討論OGM在骨髓惡性腫瘤和固態腫瘤癌症研究中的效用基因組學的會議,以及與癌症基因組學領域的傑出研究人員進行的小組討論。

技術進步在OGM產業的發展中發揮了重要作用。多年來,用於光學測繪的基礎技術已顯著改進。螢光顯微鏡等高高解析度成像技術變得越來越複雜,使研究人員能夠以前所未有的精度可視化和分析單一 DNA 分子。 DNA 標記方法和資料分析演算法的進步提高了 OGM 的準確性和效率,使其成為基因組研究可靠且強大的工具。 2023年6月,Bionano Genomics推出了Stratys系統,透過軟體進行高通量OGM,以評估骨髓惡性腫瘤的基因組資料。

此外,光學測繪技術的可及性也得到了提高,使其更廣泛地可供研究人員和研究機構使用。多家公司已開發出商業性光學測繪平台,為基因組研究提供交鑰匙解決方案。這種商業化不僅使光學測繪變得更加容易獲得,而且加速了其在各個領域的採用。

光學基因組圖譜市場報告亮點

  • 市場依產品分為設備、消耗品/試劑、軟體、服務等。 2022年的銷售佔有率為39.1%,領域佔據市場主導地位。這是由於設備的技術進步和服務提供者的增加。消耗品和試劑部門預計在預測期內將以有利的年複合成長率成長。
  • 從應用來看,結構變異檢測領域佔據市場主導地位,2022年收益佔有率為49.2%。同時,由於基因表現、基因組多樣性和複雜資料定序研究的擴展,基因組組裝領域預計將在預測期內呈現第二快的年複合成長率。
  • 按最終用途分類,學術研究機構在 2022 年佔據市場主導地位,銷售佔有率為 59.1%。同時,由於對新藥標靶和治療方法的投資增加,醫院和臨床實驗室領域預計將以 25.0% 的年複合成長率成長。
  • 按地區分類,由於生物技術領域投資和資金籌措的增加,北美地區在 2022 年以 43.4% 的最大收益佔有率佔據市場主導地位。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
  • 產業分析工具

第4章 產品經營分析

  • 光學基因組圖譜市場:產品變異分析
  • 樂器
    • 2018-2030年設備市場
  • 消耗品及試劑
    • 2018-2030年消耗品及試劑市場
  • 軟體
    • 軟體市場,2018-2030
  • 服務
    • 服務市場,2018-2030

第5章 應用業務分析

  • 光學基因組圖譜市場:應用變化分析
  • 結構變異的檢測
  • 基因組組裝
  • 微生物菌株分型
  • 其他

第6章 最終用戶業務分析

  • 光學基因組圖譜市場:最終用戶變異分析
  • 生物技術和製藥公司
    • 生物技術和製藥公司市場,2018-2030
  • 臨床實驗室
    • 臨床檢測市場,2018-2030
  • 學術研究所
    • 學術研究機構市場,2018-2030
  • 其他
    • 其他市場,2018-2030

第7章 區域業務分析

  • 2022 年及 2030 年光學基因組圖譜市場佔有率(按地區)
  • 北美洲
  • 歐洲
  • 亞太地區
  • 世界其他地區

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年企業市場分析
  • 公司簡介
    • Bionano Genomics
    • Nucleome Informatics Private Limited
    • Praxis Genomics, LLC
    • SourceBio International Limited(Source BioScience)
    • MedGenome
    • INRAE(French Plant Genomic Resources Center(CNRGV))
    • PerkinElmer(PerkinElmer Genomics)
    • Genohub Inc.
    • Hofkens Lab
    • Cerba
Product Code: GVR-4-68040-133-3

Optical Genome Mapping Market Growth & Trends:

The global optical genome mapping market size is estimated to reach USD 656.2 million by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 29.1% from 2023 to 2030. This can be attributed to developments in studying efficient treatments for a variety of chronic diseases. The ability of optical genome mapping (OGM) to complement other genomic sequencing technologies, such as next-generation sequencing (NGS), has created synergies in genomics research.

Researchers can integrate optical mapping data with NGS data to obtain a more comprehensive view of the genome, which is particularly valuable in clinical diagnostics and cancer research. In August 2023, Bionano Genomics participated in the Cancer Genomics Consortium (CGC) 2023 annual meeting with a wide range of sessions covering the utility of OGM for hematological malignancy and solid tumor cancer research, including poster presentations and scientific platform from Bionano Genomics, which also featured a panel discussion of esteemed researchers from across the cancer genomics field.

Technological advancements have played a significant role in the growth of the OGM industry. Over the years, there have been substantial improvements in the underlying technologies used in optical mapping. High-resolution imaging techniques, such as fluorescence microscopy, have become more sophisticated, enabling researchers to visualize and analyze individual DNA molecules with unprecedented precision. Advancements in DNA labeling methods and data analysis algorithms have enhanced the accuracy and efficiency of OGM, making it a reliable and robust tool for genomic research. In June 2023, Bionano Genomics introduced the Stratys system for high throughput OGM via software for evaluating genomic data for hematologic malignancies.

Moreover, the accessibility of optical mapping technology has also improved, making it more widely available to researchers and institutions. Several companies have developed commercial optical mapping platforms, offering turnkey solutions for genomics research. This commercialization has not only made optical mapping more accessible but has also accelerated its adoption across different sectors.

Optical Genome Mapping Market Report Highlights:

  • Based on product, the market is segmented into instruments, consumables and reagents, software, services, and others. The services segment dominated the market with a revenue share of 39.1% in 2022. This is attributed to the technological advancements in instruments and the increasing number of service providers. The consumables and reagents segment is expected to grow at a lucrative CAGR over the forecast period
  • Based on application, the structural variant detection segment dominated the market in 2022 with a revenue share of 49.2%. In contrast, the genome assembly segment is anticipated to exhibit the second fastest CAGR over the forecast period owing to the expanding research on gene expressions, genomic diversity, and complex data sequencing
  • Based on end-users, the academic research institutes segment dominated the market in 2022 with a revenue share of 59.1%. On the other hand, the hospitals and clinical laboratories segment is expected to grow at a lucrative CAGR of 25.0% owing to the increasing investment in new drug targets and therapeutic approaches
  • Based on region, North America dominated the market in 2022 with the largest revenue share of 43.4%, owing to the growing investments and funding in the biotechnology sector

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in genomic research
      • 3.2.1.2. Rising government funding and research initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Cost of equipment and consumables
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Optical Genome Mapping Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Consumables and Reagents
    • 4.3.1. Consumables and Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Software
    • 4.4.1. Software Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Optical Genome Mapping Market: Application Movement Analysis
  • 5.2. Structural Variant Detection
    • 5.2.1. Structural Variant Detection Market, 2018 - 2030 (USD Million)
  • 5.3. Genome Assembly
    • 5.3.1. Genome Assembly Market, 2018 - 2030 (USD Million)
  • 5.4. Microbial Strain Typing
    • 5.4.1. Microbial Strain Typing Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-user Business Analysis

  • 6.1. Optical Genome Mapping Market: End-user Movement Analysis
  • 6.2. Biotechnology and Pharmaceutical Companies
    • 6.2.1. Biotechnology and Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Clinical Laboratories
    • 6.3.1. Clinical Laboratories Market, 2018 - 2030 (USD Million)
  • 6.4. Academic research institutes
    • 6.4.1. Academic research institutes Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Optical Genome Mapping Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Optical Genome Mapping Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Optical Genome Mapping Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.6. Singapore
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Singapore Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Optical Genome Mapping Market, 2018 - 2030 (USD Million)
  • 7.5. Rest of the World
    • 7.5.1. Rest of the World Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.5.4. South Africa
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. South Africa Optical Genome Mapping Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2022
  • 8.4. Company Profiles
    • 8.4.1. Bionano Genomics
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Nucleome Informatics Private Limited
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Praxis Genomics, LLC
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. SourceBio International Limited (Source BioScience)
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. MedGenome
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. INRAE (French Plant Genomic Resources Center (CNRGV))
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. PerkinElmer (PerkinElmer Genomics)
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Genohub Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Hofkens Lab
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Cerba
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 Global optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 2 Global optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 3 Global optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 4 Global optical genome mapping market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 9 U.S. optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 12 Canada optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 15 Europe optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 19 UK optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 22 Germany optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 23 Germany optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 25 France optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 26 France optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 27 France optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 28 Italy optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 31 Spain optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 38 Japan optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 39 Japan optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 40 Japan optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 41 China optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 42 China optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 43 China optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 44 India optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 45 India optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 46 India optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 47 Australia optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 48 Australia optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 49 Australia optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 50 South Korea optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 51 South Korea optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 52 South Korea optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 53 Singapore optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 54 Singapore optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 55 Singapore optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 56 Rest of the World optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 57 Rest of the World optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 58 Rest of the World optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 59 Rest of the World optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 60 Brazil optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 61 Brazil optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 62 Brazil optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 63 Mexico optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 64 Mexico optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 65 Mexico optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 66 South Africa optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 67 South Africa optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 68 South Africa optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 69 Key companies undertaking acquisitions.
  • Table 70 Key companies launching new products/services
  • Table 71 Key companies undertaking collaborations and partnerships
  • Table 72 Key companies undertaking other initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Optical genome mapping market segmentation
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Value-chain-based sizing & forecasting
  • Fig. 10 QFD modeling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Commodity flow analysis
  • Fig. 13 Market snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Segment snapshot
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Market trends & outlook
  • Fig. 18 India disposable income, 2018 - 2020 (INR Million)
  • Fig. 19 Porter's five force analysis
  • Fig. 20 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
  • Fig. 21 Optical genome mapping market: product outlook key takeaways
  • Fig. 22 Optical genome mapping market: product movement analysis
  • Fig. 23 Instruments market, 2018 - 2030 (USD million)
  • Fig. 24 Consumables and reagents market, 2018 - 2030 (USD million)
  • Fig. 25 Software market, 2018 - 2030 (USD million)
  • Fig. 26 Services market, 2018 - 2030 (USD million)
  • Fig. 27 Optical genome mapping market: application outlook key takeaways
  • Fig. 28 Optical genome mapping market: application movement analysis
  • Fig. 29 Structural variant detection supplements market, 2018 - 2030 (USD million)
  • Fig. 30 Genome assembly supplements market, 2018 - 2030 (USD million)
  • Fig. 31 Microbial strain typing supplements market, 2018 - 2030 (USD million)
  • Fig. 32 Others supplements market, 2018 - 2030 (USD million)
  • Fig. 33 Optical genome mapping market: end-user outlook and key takeaways
  • Fig. 34 Optical genome mapping market: end-user movement analysis
  • Fig. 35 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD million)
  • Fig. 36 Clinical laboratories market, 2018 - 2030 (USD million)
  • Fig. 37 Academic research institutes market, 2018 - 2030 (USD million)
  • Fig. 38 Others market, 2018 - 2030 (USD million)
  • Fig. 39 Regional marketplace: key takeaways
  • Fig. 40 North America optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Europe optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 UK optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany optical Genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Spain optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 China optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 India optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 South Korea optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Singapore optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Rest of the World optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Mexico optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Africa optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Market participant categorization
  • Fig. 80 Strategic framework